ONL Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for ONL1204 Ophthalmic Solution
01 févr. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics to Highlight New Data in Upcoming Scientific Presentations at the 46th Annual Macula Society Meeting and the XXVth Biennial Meeting of the International Society for Eye Research
26 janv. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Durable Medical Equipment (DME) Market will Revenue to Cross US$ 282900 million in 2022 to 2028 Research by Business Opportunities, Top Companies report covers, Market-specific challenges, consumption by Regional data
17 oct. 2022 08h39 HE
|
Proficient Market Insights
PUNE, Oct. 17, 2022 (GLOBE NEWSWIRE) -- "Durable Medical Equipment (DME) Market" | No. of pages: 87| research report focus on overall information that can help to take decisions on current market...
NeuroSigma Announces Receipt of Permanent HCPCS Codes from CMS for Monarch eTNS System
27 sept. 2022 12h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Sept. 27, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced that the Centers for Medicare & Medicaid Services ("CMS") has confirmed...
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
09 févr. 2022 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Oberon Fuels Expands Team to Drive Commercial Production
30 nov. 2021 09h00 HE
|
Oberon Fuels
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Oberon Fuels, the leading provider of renewable dimethyl ether (rDME) transportation fuel, continues to expand its team as the demand continues to grow...
Oberon Fuels Appoints David Mann as Vice President, Regulatory & Government Affairs
09 nov. 2021 09h00 HE
|
Oberon Fuels
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Oberon Fuels the leading provider of renewable dimethyl ether (rDME) transportation fuel, has appointed David Mann as Vice President of Regulatory &...
U.S. Department of Energy Continues to Fund Dimethyl Ether (DME) Projects to Decarbonize Transportation
04 nov. 2021 13h20 HE
|
Oberon Fuels
SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The U.S. Department of Energy (DOE) Vehicle Technologies Office (VTO) has awarded more than $4 million in funding to test novel applications of dimethyl...
International DME Association Names Oberon Fuels Executive Cinch Munson to Leadership Posts
28 oct. 2021 12h00 HE
|
Oberon Fuels
SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The International DME Association (IDA) has appointed Cinch Munson, Vice President for Commercial Development at Oberon Fuels, to the association's...
Oberon Fuels Joins Low Carbon Fuels Coalition
20 oct. 2021 12h00 HE
|
Oberon Fuels
SACRAMENTO, Calif. and SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Oberon Fuels has joined the Low Carbon Fuels Coalition, a technology-neutral trade association with a proven track record of...